Galectin Therapeutics Inc (GALT)

Apr 27, 2026

Galectin Therapeutics to Present New Data on the Treatment of Fatty Liver Disease and Fibrosis at AA - Yahoo

Apr 27, 2026

Apr 27, 2026

Galectin Therapeutics, Inc. Investigated by the Portnoy Law Firm - GlobeNewswire

Apr 27, 2026

Apr 26, 2026

Galectin Therapeutics (GALT) upgraded to buy: What does it mean for the stock? - MSN

Apr 26, 2026

Apr 25, 2026

GALT Price Today: Galectin Therapeutics Inc. Stock Price, Quote & Chart | MEXC - MEXC Exchange

Apr 25, 2026

Apr 24, 2026

GALT Stock Price, Quote & Chart | GALECTIN THERAPEUTICS INC (NASDAQ:GALT) - ChartMill

Apr 24, 2026

Apr 22, 2026

GALT (Galectin Therapeutics Inc.) Q4 2025 narrower than expected loss drives 8.41 percent share gain amid positive investor sentiment.Earnings Per Share - UBND thành phố Hải Phòng

Apr 22, 2026

Apr 22, 2026

GALT (Galectin Therapeutics Inc.) posts narrower Q4 2025 loss than estimates, shares gain 3.64 percent on upbeat investor reaction.Expert Momentum Signals - Cổng thông tin điện tử tỉnh Tây Ninh

Apr 22, 2026

Apr 20, 2026

Is institutional money buying Galectin Therapeutics (GALT) stock (Smart Money Exits) 2026-04-20Open Stock Signal Network - UBND thành phố Hải Phòng

Apr 20, 2026

Apr 13, 2026

Buy Signal: What is the long term forecast for Galectin Therapeutics Inc stockTrade Analysis Report & Consistent Profit Trading Strategies - baoquankhu1.vn

Apr 13, 2026

Apr 13, 2026

[EFFECT] GALECTIN THERAPEUTICS INC SEC Filing - Stock Titan

Apr 13, 2026

Apr 10, 2026

Targets Report: Whats next for Galectin Therapeutics Inc stockBond Market & Weekly Setup with High ROI Potential - baoquankhu1.vn

Apr 10, 2026

Apr 10, 2026

Dip Buying: Can Galectin Therapeutics Inc weather a recession2026 Major Catalysts & Weekly Stock Performance Updates - baoquankhu1.vn

Apr 10, 2026

Apr 09, 2026

Is Galectin Therapeutics (GALT) Stock Reacting to Market | Price at $2.37, Up 6.76%Pro Level Trade Signals - Newser

Apr 09, 2026

Apr 07, 2026

Earnings Risk: Is Galectin Therapeutics Inc stock a buy or sell2026 Key Highlights & Smart Swing Trading Techniques - baoquankhu1.vn

Apr 07, 2026

Apr 06, 2026

Trend Recap: What is the long term forecast for Galectin Therapeutics Inc stock2026 Summary & Consistent Return Investment Signals - baoquankhu1.vn

Apr 06, 2026

Apr 06, 2026

Is Galectin Therapeutics (GALT) Stock Worth Holding | Price at $2.61, Down 2.25%Market Movers - Newser

Apr 06, 2026

Apr 05, 2026

Galectin Therapeutics (GALT) Eps Diluted (TTM) - Zacks Investment Research

Apr 05, 2026

Apr 03, 2026

Galectin Therapeutics Inc. (PHPN.F) Analyst insights, Price targets and Recommendations - Yahoo Finance Singapore

Apr 03, 2026

Apr 03, 2026

Galectin Therapeutics (GALT) Receives Buy Rating: How Will This Impact the Shares? - Bitget

Apr 03, 2026

Apr 03, 2026

Galectin Therapeutics (GALT) Upgraded to Buy: What Does It Mean for the Stock? - Yahoo Finance

Apr 03, 2026

Apr 03, 2026

HC Wainwright Boosts FY2026 Earnings Estimate for Galectin Therapeutics - National Today

Apr 03, 2026

Apr 03, 2026

FY2026 Earnings Estimate for GALT Issued By HC Wainwright - marketbeat.com

Apr 03, 2026

Apr 02, 2026

Aug PostEarnings: Can Galectin Therapeutics Inc reach all time highs this year2026 Trading Recap & Verified Swing Trading Watchlist - baoquankhu1.vn

Apr 02, 2026

Apr 02, 2026

What is HC Wainwright's Estimate for GALT Q1 Earnings? - MarketBeat

Apr 02, 2026

Apr 01, 2026

Galectin Therapeutics Inc reports results for the quarter ended December 31Earnings Summary - TradingView

Apr 01, 2026

Apr 01, 2026

Galectin Therapeutics Reports 2025 Financial Results, Advances Belapectin Program for MASH Cirrhosis, and Extends Cash Runway Through 2027 - Minichart

Apr 01, 2026

Mar 31, 2026

Galectin Therapeutics (NASDAQ: GALT) launches $32.5M ATM; 3% agent fee - Stock Titan

Mar 31, 2026

Mar 31, 2026

GALT SEC FilingsGalectin Therapeutics Inc 10-K, 10-Q, 8-K Forms - Stock Titan

Mar 31, 2026

Mar 31, 2026

Galectin Therapeutics Reports 2025 Financial Results - National Today

Mar 31, 2026

Mar 31, 2026

Galectin Therapeutics Inc. (GALT) Stock Price, News, Quote & History - Yahoo! Finance Canada

Mar 31, 2026

Mar 31, 2026

Galectin Therapeutics 2025 Annual Report: Clinical Trials, Regulatory Challenges, and Biopharma Industry Risks - Minichart

Mar 31, 2026

Mar 31, 2026

Galectin Therapeutics (NASDAQ:GALT) Posts Quarterly Earnings Results, Beats Expectations By $0.02 EPS - MarketBeat

Mar 31, 2026

Mar 31, 2026

Liver drug developer Galectin Therapeutics' 2025 net loss narrows on reduced R&D costs - TradingView

Mar 31, 2026

Mar 31, 2026

Galectin Therapeutics Reports 2025 Financial Results and Provides Business Update - Yahoo Finance

Mar 31, 2026

Mar 31, 2026

NAVIGATE MASH data and funding risks at Galectin (NASDAQ: GALT) - Stock Titan

Mar 31, 2026

Mar 31, 2026

Belapectin data and $30.8M 2025 loss at Galectin (NASDAQ: GALT) - Stock Titan

Mar 31, 2026

Mar 31, 2026

Galectin Therapeutics 10-K: R&D cuts reduce cash burn; cash runway to Apr 2027 - TradingView

Mar 31, 2026

Mar 31, 2026

Galectin Therapeutics Inc. Reports Earnings Results for the Full Year Ended December 31, 2025 - marketscreener.com

Mar 31, 2026

Mar 30, 2026

What makes Galectin Therapeutics Inc stock attractive today2026 Trade Ideas & Low Risk High Win Rate Picks - baoquankhu1.vn

Mar 30, 2026

Mar 30, 2026

Galectin Therapeutics Short Interest Rises 27% in March - National Today

Mar 30, 2026

Mar 30, 2026

Galectin Therapeutics Inc. (NASDAQ:GALT) Short Interest Up 27.0% in March - MarketBeat

Mar 30, 2026

Mar 30, 2026

Risk Recap: Is Galectin Therapeutics Inc in a bullish channel2026 Historical Comparison & Risk Managed Investment Entry Signals - baoquankhu1.vn

Mar 30, 2026

Mar 27, 2026

Retail Trends: Is Galectin Therapeutics Inc gaining market share2026 Growth vs Value & Weekly Top Gainers Alerts - baoquankhu1.vn

Mar 27, 2026

Mar 27, 2026

Galectin Therapeutics Inc expected to post a loss of 10 cents a shareEarnings Preview - TradingView

Mar 27, 2026